Dr Uazman Alam BSc, MBChB, MPHe, MRCP(UK)(London), PhD

Senior Clinical Lecturer & Honorary Consultant Physician Cardiovascular & Metabolic Medicine

About

Personal Statement

I obtained a BSc in Medical Science from the University of St. Andrews, and subsequently went onto the University of Manchester to study Medicine (MBChB) from which graduated in 2005. Part way through the MBChB, I completed an MSc in population Health (MPHe) in which I undertook evidence based reviews on treatments for painful diabetic neuropathy. My Interest in neuropathic pain stemmed from this work. The genesis of my research education began whilst working on peripheral nerve histology in experimental rat and baboon models of diabetic neuropathy as a fourth year medical student. Prior to entering higher specialist training in Endocrinology and Diabetes, I pursued a PhD in Diabetic Neuropathy and Vitamin D at University of Manchester from which I graduated in 2014. During this time, I worked on large NIH and JDRF funded projects defining novel surrogate markers for small fibre neuropathy which have been published in leading journals such as Diabetes and Diabetes Care. My clinical and research expertise lie in pathogenesis, assessment and treatment of diabetic neuropathy and I have published over 120 pubmed-cited journal publications. I have presented on this both nationally and internationally.

I was appointed as a Senior Clinical Lecturer and Honorary Consultant Physician in Endocrinology and Diabetes in April 2017 at the University of Liverpool. I am a member of the Royal College of Physicians, NeuroDiab, Diabetes UK and I am a council member for Lipids, Metabolism and Vascular Risk section of the Royal Society of Medicine, Associated Editor for Clinical Medicine (RCP Journal) and Topic Editor for Clinical Therapeutics, and a regular peer reviewer to several leading journals in the field of diabetes including, NEJM, Diabetes Care, Obesity & Metabolism, Diabetic Medicine to name a few.

My work at University of Liverpool will continue to focus on non-invasive surrogate endpoints of peripheral neuropathies and pain syndromes with an additional focus on cardiovascular disease in diabetes and obesity.